Congresses and Meetings

An article in November’s Ophthalmology talks about ultra-small drainage devices for use in facilitating drainage and therefore reducing intraocular pressure in some glaucoma patients. Results presented at AAO meeting this week suggest the Ivantis Hydrus microstent is clinically effective.

Good time of year to be launching new products internationally, as Orthofix trumpets the introduction of its new spinal fixation system in advance of Italy’s SIOT and France’s SOFCOT events.

If you negotiate your way around all 19 halls you’ll know what the title means. Medica is a staggering display of medical devices and technologies that leaves the visitor or exhibitor tired and in need of “bier und würst”. the show starts on Wednesday 14th.

Boston Scientific Corporation and the University of Rochester Medical Center have shown that improved programming of Boston Scientific dual-chamber ICD or CRT-D heart devices can reduce inappropriate therapy and risk of death.

Data from the St.Jude EnligHTN I multi-electrode renal denervation catheter study presented at the annual scientific meeting of the American Heart Association suggests blood pressure reduction is sustained at six months.

Teleflex Incorporated has announced the U.S. launch of its new Arrow® FlexBlock™ Continuous Peripheral Nerve Block Catheter at the annual meeting of the American Society of Anesthesiologists, and product will begin shipping to customers in November.

Varian Medical Systems has been showcasing the company’s technologies for the non-invasive treatment of lung cancer at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston this week.

On-X® Life Technologies, Inc. has launched two new heart valve products at EACTS, the On-X® Aortic Prosthetic Valve with Anatomic Sewing Ring and an ePTFE suture Chord-X® for repair and replacement of mitral valve chordae tendeneae.

Data demonstrate high procedural success and low paravalvular leak for Medtronic’s new Engager TAVI offering in late-breaking trials session at the European Association for Cardio-Thoracic Surgery annual meeting.

Micell Technologies, Inc. has announced positive data from two clinical studies of its investigational MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES™), a thin-strut drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating designed to control drug release.

Why does the humble press release provoke such a lack of attention amongst PR marketers except at congress time? We explore the arguments and decide the art may be dying, but should remain a core component of the coordinated marcoms plan.

DePuy Synthes Spine has announced new image guided instrumentation for two of its leading spine systems and has entered into a new partnership agreement with Brainlab, enabling both companies to offer integrated surgical navigation and imaging solutions.

Results from St.Jude’s RESPECT PFO trial presented at TCT 2012 show that the primary analysis was not statistically significant but trended towards superiority, while additional analyses demonstrated superiority.

Osseon® Therapeutics, Inc. announced today the commercial release in the U.S. of its newest product, the Osseoflex® SB steerable inflatable bone tamp. After successful launch and distribution in Europe, the Osseoflex SB has received FDA clearance for sale in the U.S.

DePuy Synthes Spine has announced the launch of the Spotlight® PL Access System, the first access system designed specifically for minimally invasive posterior-lateral fusion.

Prolific spinal device company K2M, Inc., has announced the global expansion of its breakthrough Rail 4D™ Technology at the 2012 North American Spine Society (NASS) Annual Meeting in Dallas, Texas. The technology is said to address the most complex spinal curves.